{
    "startDate": "2020-01-01",
    "endDate": "2020-12-31",
    "year": "2020",
    "quarter": "FY",
    "symbol": "PSTV",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 8346000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 829000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 9175000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1820000
            },
            {
                "label": "Operating lease right-use-of assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 636000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 372000
            },
            {
                "label": "Intangible assets, net",
                "concept": "OtherIntangibleAssetsNet",
                "unit": "usd",
                "value": 86000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 16000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 12105000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2081000
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 123000
            },
            {
                "label": "Term loan obligation, net of discount",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 6335000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 8539000
            },
            {
                "label": "Noncurrent operating lease liability",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 528000
            },
            {
                "label": "Warrant liability",
                "concept": "WarrantsAndRightsOutstanding",
                "unit": "usd",
                "value": 7000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 9074000
            },
            {
                "label": "Commitments and contingencies (Note 7)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,954 and 1,959 shares issued and outstanding in 2020 and 2019, respectively",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value; 100,000,000 shares authorized; 6,749,028 and 3,880,588 shares issued and outstanding in 2020 and 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 7000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 436535000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -433511000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 3031000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 12105000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8241000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 366000
            },
            {
                "label": "Amortization of deferred financing costs and debt discount",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 584000
            },
            {
                "label": "In process research and development acquired from NanoTx Therapeutics",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 781000
            },
            {
                "label": "Change in fair value of liability instruments",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -2400000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 247000
            },
            {
                "label": "Inventory write off",
                "concept": "InventoryWriteDown",
                "unit": "usd",
                "value": 107000
            },
            {
                "label": "Non cash lease expense.",
                "concept": "pstv:NonCashLeaseExpense",
                "unit": "usd",
                "value": 3000
            },
            {
                "label": "Loss on sale of business",
                "concept": "GainLossOnSaleOfBusiness",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Issuance cost of warrants.",
                "concept": "pstv:IssuanceCostOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -1169000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other current assets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": -126000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": -58000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -1234000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "IncreaseDecreaseInOtherNoncurrentLiabilities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows used in operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -8434000
            },
            {
                "label": "Payments to acquire property plant and equipment and intangible assets.",
                "concept": "pstv:PaymentsToAcquirePropertyPlantAndEquipmentAndIntangibleAssets",
                "unit": "usd",
                "value": 93000
            },
            {
                "label": "In process research and development acquired from NanoTx Therapeutics",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 400000
            },
            {
                "label": "Proceeds from sale of business",
                "concept": "ProceedsFromDivestitureOfBusinesses",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from (used in) investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -493000
            },
            {
                "label": "Principal payments of long-term obligations",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 5307000
            },
            {
                "label": "Payment of financing lease liability",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": 117000
            },
            {
                "label": "Proceeds from warrant exercises.",
                "concept": "pstv:ProceedsFromWarrantExercises1",
                "unit": "usd",
                "value": 1098000
            },
            {
                "label": "Proceeds from sale of common stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 4007000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -319000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -9246000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 567000
            },
            {
                "label": "Issuance costs paid in common stock",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 463000
            },
            {
                "label": "Common stock issued in payment for in process research and development.",
                "concept": "pstv:CommonStockIssuedInPaymentForInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 381000
            },
            {
                "label": "Unpaid Offering Costs.",
                "concept": "pstv:UnpaidOfferingCosts",
                "unit": "usd",
                "value": 125000
            },
            {
                "label": "Reclassifications of warrants upon exercise from liability to equity.",
                "concept": "pstv:ReclassificationsOfWarrantsUponExerciseFromLiabilityToEquity",
                "unit": "usd",
                "value": 4504000
            },
            {
                "label": "Non cash or part non cash divestiture amount of consideration used for principal payment of long term obligations.",
                "concept": "pstv:NonCashOrPartNonCashDivestitureAmountOfConsiderationUsedForPrincipalPaymentOfLongTermObligations",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Offering cost paid in warrants.",
                "concept": "pstv:OfferingCostPaidInWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Beneficial conversion feature for convertible preferred stock",
                "concept": "PreferredStockDividendsAndOtherAdjustments",
                "unit": "usd",
                "value": 0
            }
        ],
        "ic": [
            {
                "label": "Revenue earned during the period from non-product related activities and revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in government contract and other agreements.",
                "concept": "pstv:GovernmentContractsAndOther",
                "unit": "usd",
                "value": 303000
            },
            {
                "label": "Aggregate revenue earned during the period from recognition of related party deferred revenue, non-product related activities and revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.",
                "concept": "pstv:DevelopmentRevenues",
                "unit": "usd",
                "value": 303000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 2700000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 6406000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 9887000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -9584000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 50000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 1107000
            },
            {
                "label": "Change in fair value of liability instruments",
                "concept": "LiabilitiesFairValueAdjustment",
                "unit": "usd",
                "value": 2400000
            },
            {
                "label": "Issuance cost of warrants.",
                "concept": "pstv:IssuanceCostOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Total other expense",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 1343000
            },
            {
                "label": "Loss from continuing operations",
                "concept": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -8241000
            },
            {
                "label": "Loss from discontinued operations",
                "concept": "IncomeLossFromDiscontinuedOperationsNetOfTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8241000
            },
            {
                "label": "Beneficial conversion feature for convertible preferred stock",
                "concept": "PreferredStockDividendsAndOtherAdjustments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net loss allocable to common stockholders - continuing operations",
                "concept": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
                "unit": "usd",
                "value": -8241000
            },
            {
                "label": "Net loss allocable to common stockholders - discontinued operations",
                "concept": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net loss allocable to common stockholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -8241000
            },
            {
                "label": "Basic and diluted net loss per share attributable to common stockholders - continuing operations",
                "concept": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
                "unit": "usd/shares",
                "value": -1.86
            },
            {
                "label": "Basic and diluted net loss per share attributable to common stockholders - discontinued operations",
                "concept": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare",
                "unit": "usd/shares",
                "value": 0
            },
            {
                "label": "Net loss per share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -1.86
            },
            {
                "label": "Basic and diluted weighted average shares used in calculating net loss per share attributable to common stockholders",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 4427835
            }
        ]
    }
}